Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/10789
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Azad, Arun A | en |
dc.contributor.author | Chong, Geoffrey | en |
dc.contributor.author | Tauro, A | en |
dc.contributor.author | Aly, Ahmad | en |
dc.contributor.author | Tebbutt, Niall C | en |
dc.date.accessioned | 2015-05-16T00:21:18Z | - |
dc.date.available | 2015-05-16T00:21:18Z | - |
dc.date.issued | 2009-03-19 | en |
dc.identifier.citation | Medical Oncology (northwood, London, England) 2009; 27(2): 230-2 | en |
dc.identifier.govdoc | 19296240 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/10789 | en |
dc.description.abstract | We present the case of a 65-year-old male with squamous cell carcinoma of the thoracic oesophagus on a background of neurofibromatosis type 1. On computed tomography, he was noted to have a large left-sided superior mediastinal mass. Initially, this mass was thought to be metastatic lymphadenopathy; however, it did not display fluorodeoxyglucose uptake on positron emission tomography. Subsequent biopsy confirmed the mass to be a neurofibroma and the patient commenced definitive chemo-radiation. Positron emission tomography had a major impact on management since the presumed lymph node disease was not included in the radiation field. In addition, positron emission tomography altered prognostic stratification since lymph node involvement is a poor prognostic factor in oesophageal cancer. We could only identify one other case in the English literature in which positron emission tomography was used to distinguish metastatic carcinoma from a neurofibroma, although there are a number of reports that describe the utility of positron emission tomography in differentiating benign neurofibromas from malignant connective tissue tumours. | en |
dc.language.iso | en | en |
dc.subject.other | Aged | en |
dc.subject.other | Diagnosis, Differential | en |
dc.subject.other | Esophageal Neoplasms.diagnosis.radionuclide imaging.secondary | en |
dc.subject.other | Fluorodeoxyglucose F18.diagnostic use | en |
dc.subject.other | Humans | en |
dc.subject.other | Male | en |
dc.subject.other | Neurofibroma.diagnosis.radionuclide imaging | en |
dc.subject.other | Positron-Emission Tomography | en |
dc.title | 18F-FDG-PET imaging of a benign neurofibroma masquerading as metastatic oesophageal carcinoma. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Medical oncology (Northwood, London, England) | en |
dc.identifier.affiliation | Ludwig Institute Oncology Unit, University of Melbourne, Austin Hospital, Austin Health, Heidelberg, Victoria, Australia, Australia | en |
dc.identifier.doi | 10.1007/s12032-009-9196-x | en |
dc.description.pages | 230-2 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/19296240 | en |
dc.type.austin | Journal Article | en |
local.name.researcher | Aly, Ahmad | |
item.languageiso639-1 | en | - |
item.fulltext | With Fulltext | - |
item.grantfulltext | open | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.openairetype | Journal Article | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Medical Oncology | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
Appears in Collections: | Journal articles |
Files in This Item:
File | Size | Format | |
---|---|---|---|
19296240.pdf | 44.46 kB | Adobe PDF | View/Open |
Page view(s)
70
checked on Dec 27, 2024
Download(s)
92
checked on Dec 27, 2024
Google ScholarTM
Check
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.